These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 27262599

  • 1. Design, synthesis and anti-cancer activity evaluation of podophyllotoxin-norcantharidin hybrid drugs.
    Han HW, Qiu HY, Hu C, Sun WX, Yang RW, Qi JL, Wang XM, Lu GH, Yang YH.
    Bioorg Med Chem Lett; 2016 Jul 15; 26(14):3237-3242. PubMed ID: 27262599
    [Abstract] [Full Text] [Related]

  • 2. Design and synthesis of piperazine acetate podophyllotoxin ester derivatives targeting tubulin depolymerization as new anticancer agents.
    Sun WX, Ji YJ, Wan Y, Han HW, Lin HY, Lu GH, Qi JL, Wang XM, Yang YH.
    Bioorg Med Chem Lett; 2017 Sep 01; 27(17):4066-4074. PubMed ID: 28757065
    [Abstract] [Full Text] [Related]

  • 3. Design, synthesis, biological evaluation, and 3D-QSAR analysis of podophyllotoxin-dioxazole combination as tubulin targeting anticancer agents.
    Wang ZZ, Sun WX, Wang X, Zhang YH, Qiu HY, Qi JL, Pang YJ, Lu GH, Wang XM, Yu FG, Yang YH.
    Chem Biol Drug Des; 2017 Aug 01; 90(2):236-243. PubMed ID: 28079286
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and biological evaluation of podophyllotoxin congeners as tubulin polymerization inhibitors.
    Kamal A, Srinivasa Reddy T, Polepalli S, Shalini N, Reddy VG, Subba Rao AV, Jain N, Shankaraiah N.
    Bioorg Med Chem; 2014 Oct 01; 22(19):5466-75. PubMed ID: 25131956
    [Abstract] [Full Text] [Related]

  • 5. Investigation of podophyllotoxin esters as potential anticancer agents: synthesis, biological studies and tubulin inhibition properties.
    Shareef MA, Duscharla D, Ramasatyaveni G, Dhoke NR, Das A, Ummanni R, Srivastava AK.
    Eur J Med Chem; 2015 Jan 07; 89():128-37. PubMed ID: 25462233
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and biological evaluation of a series of podophyllotoxins derivatives as a class of potent antitubulin agents.
    Liu Y, Wei D, Zhao Y, Cheng W, Lu Y, Ma Y, Li X, Han C, Wei Y, Cao H, Zhao C.
    Bioorg Med Chem; 2012 Nov 01; 20(21):6285-95. PubMed ID: 23022053
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and biological evaluation of podophyllotoxin derivatives as selective antitumor agents.
    Wu GR, Xu B, Yang YQ, Zhang XY, Fang K, Ma T, Wang H, Xue NN, Chen M, Guo WB, Jia XH, Wang PL, Lei HM.
    Eur J Med Chem; 2018 Jul 15; 155():183-196. PubMed ID: 29886322
    [Abstract] [Full Text] [Related]

  • 8. Conjugates of podophyllotoxin and norcantharidin as dual inhibitors of topoisomeraseⅡ and protein phosphatase 2A.
    Tang ZB, Chen YZ, Zhao J, Guan XW, Bo YX, Chen SW, Hui L.
    Eur J Med Chem; 2016 Nov 10; 123():568-576. PubMed ID: 27517805
    [Abstract] [Full Text] [Related]

  • 9. 4β-[(4-Alkyl)-1,2,3-triazol-1-yl] podophyllotoxins as anticancer compounds: design, synthesis and biological evaluation.
    Reddy DM, Srinivas J, Chashoo G, Saxena AK, Sampath Kumar HM.
    Eur J Med Chem; 2011 Jun 10; 46(6):1983-91. PubMed ID: 21477899
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and biological evaluation of a novel artesunate-podophyllotoxin conjugate as anticancer agent.
    Zhang L, Chen F, Zhang Z, Chen Y, Wang J.
    Bioorg Med Chem Lett; 2016 Jan 01; 26(1):38-42. PubMed ID: 26615886
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and cytotoxic activity on human cancer cells of carbamate derivatives of 4β-(1,2,3-triazol-1-yl)podophyllotoxin.
    Liu JF, Sang CY, Xu XH, Zhang LL, Yang X, Hui L, Zhang JB, Chen SW.
    Eur J Med Chem; 2013 Jun 01; 64():621-8. PubMed ID: 23711769
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. One-pot synthesis and biological evaluation of N-(aminosulfonyl)-4-podophyllotoxin carbamates as potential anticancer agents.
    Xu XH, Guan XW, Feng SL, Ma YZ, Chen SW, Hui L.
    Bioorg Med Chem Lett; 2017 Jul 01; 27(13):2890-2894. PubMed ID: 28512026
    [Abstract] [Full Text] [Related]

  • 14. 4β-amidotriazole linked podophyllotoxin congeners: DNA topoisomerase-IIα inhibition and potential anticancer agents for prostate cancer.
    Reddy VG, Bonam SR, Reddy TS, Akunuri R, Naidu VGM, Nayak VL, Bhargava SK, Kumar HMS, Srihari P, Kamal A.
    Eur J Med Chem; 2018 Jan 20; 144():595-611. PubMed ID: 29289884
    [Abstract] [Full Text] [Related]

  • 15. A rational design strategy of the novel topoisomerase II inhibitors for the synthesis of the 4-O-(2-pyrazinecarboxylic)-4'-demethylepipodophyllotoxin with antitumor activity by diminishing the relaxation reaction of topoisomerase II-DNA decatenation.
    Zhao W, Chen L, Li HM, Wang DJ, Li DS, Chen T, Yuan ZP, Tang YJ.
    Bioorg Med Chem; 2014 Jun 01; 22(11):2998-3007. PubMed ID: 24775914
    [Abstract] [Full Text] [Related]

  • 16. Aromatic heterocyclic esters of podophyllotoxin exert anti-MDR activity in human leukemia K562/ADR cells via ROS/MAPK signaling pathways.
    Zhang L, Zhang Z, Chen F, Chen Y, Lin Y, Wang J.
    Eur J Med Chem; 2016 Nov 10; 123():226-235. PubMed ID: 27484511
    [Abstract] [Full Text] [Related]

  • 17. Synthesis of d-ring modified acid hydrazide derivatives of podophyllotoxin and their anticancer studies as Tubulin inhibiting agents.
    Nerella S, Kankala S, Paidakula S, Gavaji B.
    Bioorg Chem; 2020 Jan 10; 94():103384. PubMed ID: 31776036
    [Abstract] [Full Text] [Related]

  • 18. Novel Podophyllotoxin Derivatives as Potential Tubulin Inhibitors: Design, Synthesis, and Antiproliferative Activity Evaluation.
    Han HW, Lin HY, He DL, Ren Y, Sun WX, Liang L, Du MH, Li DC, Chu YC, Yang MK, Wang XM, Yang YH.
    Chem Biodivers; 2018 Nov 10; 15(11):e1800289. PubMed ID: 30194898
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.